Areas of expertise: Parkinson’s disease, movement disorders, therapy development, preclinical studies, prion-like pathogenesis
Dr. Jeffrey H. Kordower holds a joint appointment as a professor in Van Andel Research Institute’s Center for Neurodegenerative Science. His primary appointment is at Rush University Medical Center, where he is the Jean Schweppe-Armour Professor of Neurological Sciences, professor of neurosurgery, director of the Research Center for Brain Repair, section head of the Division of Neuroscience and director of the Neuroscience Graduate Program.
He received his B.A. and M.A. from the City University of New York (CUNY) and his Ph.D. from that same institution in 1984. In 2004, he received an honorary doctorate of science degree from CUNY in recognition of his achievements.
Dr. Kordower is an international authority in the area of age-related movement disorders, with special expertise in experimental therapeutics and pathogenesis. His laboratory is particularly well known for designing and conducting critical preclinical studies required to translate experimental therapeutics into clinical trials, specifically numerous gene and cell therapy preclinical studies that he and his clinical colleagues have translated to patients with Parkinson’s disease.
He has published close to 400 manuscripts and book chapters and served on more than 20 journal editorial boards (including as either a section head or associate editor on three—Journal of Comparative Neurology, Movement Disorders, and Neurobiology of Aging). He is the past president of the American Society of Neural Transplantation (now American Society of Neural Therapy and Repair), served on the program committee for the World Parkinson’s Congress, and is a founding Scientific Advisory Board (SAB) member and past Executive Committee SAB member for the Michael J. Fox Foundation for Parkinson’s Research. He currently serves on the International Executive Committee for the Movement Disorders Society.